CAR2219
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR2219, covering 2025-02-19 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma [Phase 1, Phase 2]